CCThe company shows mixed signals across fundamental, technical, and thematic factors. While some fundamental metrics like profitability are strong, concerns arise from its current valuation and negative free cash flow. Technical indicators present a generally bullish trend with some overbought conditions, and the thematic outlook is neutral with no dominant growth drivers identified.
The company operates in established chemical sectors with moderate growth prospects. No significant unique thematic tailwinds or headwinds are apparent from the provided data.
The company demonstrates solid profitability and revenue generation, but its valuation metrics are mixed, and recent free cash flow has been negative. The balance sheet appears manageable, with a significant debt load offset by substantial assets.
The stock exhibits a strong upward trend across multiple timeframes, supported by moving averages. While some oscillators indicate overbought conditions, the overall momentum remains positive, suggesting potential for further gains, though short-term consolidation is possible.
| Factor | Score |
|---|---|
| Specialty Chemicals Demand | 60 |
| Sustainability Trends | 55 |
| Market Competition | 50 |
| Regulatory Impact | 40 |
| Factor | Score |
|---|---|
| Valuation | 30 |
| Profitability | 60 |
| Growth | 40 |
| Balance Sheet Health | 45 |
| Cash Flow | 20 |
| Factor | Score |
|---|---|
| Trend Analysis | 85 |
| Momentum | 70 |
| Short-Term Momentum | 75 |
| Support and Resistance | 70 |
| Short-Term Overbought | 65 |
Positive EPS Surprise
The company has reported positive earnings surprises in its last two quarters, exceeding analyst expectations by 75.0% and 22.15% respectively.
Attractive Forward P/E Ratio
The forward Price-to-Earnings (P/E) ratio is 19.2, which is lower than the industry average of 23.5, suggesting potential undervaluation relative to future earnings.
High P/E Ratio (TTM)
The trailing Price-to-Earnings (P/E) ratio is -52.0, which is significantly high and suggests that the stock may be overvalued based on current earnings.
Negative EPS Surprise in Recent Quarters
The company reported negative earnings surprises in Q2 2025 (-38.88%) and Q1 2025 (-5.44%), indicating a recent trend of missing analyst expectations.
May 2025
16
Ex-Dividend Date
June 2025
16
Next Dividend Date
August 2025
1
Next Earnings Date
H: $0.57
A: $0.48
L: $0.38
H: 1.59B
A: 1.58B
L: 1.58B
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. The company sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.
14.67 USD
The 39 analysts offering 1 year price forecasts for CC have a max estimate of 20.00 and a min estimate of 11.00.